Genotype 3 Infection: The Last Stand of Hepatitis C Virus.
Genotype 3 Infection: The Last Stand of Hepatitis C Virus.
复制标题
DOI:
10.1007/s40265-016-0685-x
复制
发表时间:
2017-03
期刊:
影响因子:
11.5
通讯作者:
Naggie S
中科院分区:
文献类型:
--
作者:
Chan A;Patel K;Naggie S
Hepatitis C Virus(HCV) represents a significant global disease burden with an estimated 130 – 150 million people worldwide living with chronic HCV infection. Within the 6 major clinical HCV genotypes, genotype 3 represents 22–30% of all infection, and is described as a unique entity with higher rates of steatosis, faster progression to cirrhosis, and higher rates of hepatocellular carcinoma. Hepatic steatosis in the setting of hepatitis C genotype 3 (HCV-3) is driven by viral influence on three major pathways: microsomal triglyceride transfer protein, sterol regulatory element-binding protein-1c, and peroxisome proliferator associated receptor-α. Historically with DAAs, the rates of cure for HCV-3 therapies lagged behind the other genotypes. As current therapies for HCV genotype 3 continue to close this gap, it is important to be cognizant of common drug interactions such as acid suppressing medication and amiodarone. In this review, we discuss the rates of steatosis in HCV-3, the mechanisms behind HCV-3 specific steatosis, and current and future therapies.
登录
查看更多内容
影响因子:
158.5
作者:
Foster, G. R.;Afdhal, N.;Sulkowski, M.
通讯作者:
Sulkowski, M.
影响因子:
2.5
作者:
De Meyer, S.;Ghys, A.;Picchio, G.
通讯作者:
Picchio, G.
影响因子:
4.3
作者:
Cheng, Yang;Dharancy, Sebastien;Desreumaux, Pierre
通讯作者:
Desreumaux, Pierre
影响因子:
7.6
作者:
De Gottardi, A;Pazienza, V;Negro, F
通讯作者:
Negro, F
影响因子:
13.5
作者:
Bedossa, Pierre;Moucari, Rami;Marcellin, Patrick
通讯作者:
Marcellin, Patrick